|
🐜
|
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
250 auth.
T. Mok,
Yi‐Long Wu,
I. Kudaba,
D. Kowalski,
B. Cho,
H. Turna,
G. Castro,
V. Srimuninnimit,
K. Laktionov,
I. Bondarenko,
K. Kubota,
G. Lubiniecki,
Jin Zhang,
D. Kush,
G. Lopes,
...
G. Adamchuk,
M. Ahn,
A. Alexandru,
O. Altundag,
A. Alyasova,
O. Andrusenko,
K. Aoe,
A. Araújo,
O. Aren,
O. Rodriguez,
T. Ativitavas,
Oscar Avendano,
F. Barata,
C. Barrios,
C. Beato,
Per Bergstrom,
D. Betticher,
L. Bolotina,
Michiel Botha,
Sayeuri Buddu,
C. Caglevic,
A. Cardona,
H. Castro,
F. Senler,
Carlos Alexandre Sydow Cerny,
A. Česas,
G. Chan,
Jian-hua Chang,
Gongyan Chen,
Xi Chen,
S. Cheng,
Ying Cheng,
N. Cherciu,
C. Chiu,
S. Cicėnas,
D. Ciurescu,
G. Cohen,
Marcos André Costa,
P. Danchaivijitr,
F. D. Angelis,
S. Azevedo,
M. Dediu,
Ts Deliverski,
P. Marchi,
Flor de The Bustamante Valles,
Z. Ding,
Boyan Doganov,
L. Dreosti,
R. Duarte,
Regina Edusma-Dy,
S. Emelyanov,
M. Erman,
Yun Fan,
L. Fein,
Jifeng Feng,
D. Fenton,
G. Fernandes,
C. Ferreira,
F. Franke,
H. Freitas,
Y. Fujisaka,
H. Galindo,
Christina Galvez,
D. Ganea,
N. Gil,
G. Girotto,
E. Goker,
T. Goksel,
Gonzalo Gomez Aubin,
Luis Gomez Wolff,
H. Griph,
M. Gumus,
Jacqueline M. Hall,
Greg Hart,
L. Havel,
Jianxing He,
Yong He,
C. Hernández,
V. Hespanhol,
T. Hirashima,
Chung-man. Ho,
A. Horiike,
Y. Hosomi,
K. Hotta,
M. Hou,
S. How,
T. Hsia,
Yi Hu,
M. Ichiki,
F. Imamura,
O. Ivashchuk,
Y. Iwamoto,
J. Jaal,
J. Jassem,
Christa Jordaan,
R. Juergens,
D. Kaen,
E. Kalinka‐Warzocha,
N. Karaseva,
B. Karaszewska,
A. Każarnowicz,
K. Kasahara,
N. Katakami,
T. Kato,
T. Kawaguchi,
J. Kim,
K. Kishi,
V. Kolek,
Marchela Koleva,
P. Kolman,
L. Koubková,
R. Kowalyszyn,
D. Kowalski,
K. Koynov,
D. Ksienski,
T. Kurata,
G. Kuusk,
L. Kuzina,
I. Laczó,
G. Ladrera,
K. Laktionov,
G. Landers,
S. Lazarev,
G. Lerzo,
Krzysztof Lesniewski- Kmak,
Wei Li,
C. Liam,
Igor Lifirenko,
O. Lipatov,
Xiaoqing Liu,
Zhe Liu,
S. Lo,
Valéria Lopes,
K. Lopez,
Shun Lu,
G. Martinengo,
L. Mas,
M. Matrosova,
Rumyana Micheva,
Z. Milanova,
L. Miron,
Tony Mok,
M. Molina,
S. Murakami,
Y. Nakahara,
Tien Quang Nguyen,
T. Nishimura,
A. Ochsenbein,
T. Ohira,
Ronny Ohman,
C. Ong,
G. Ostoros,
X. Ouyang,
E. Ovchinnikova,
O. Ozyılkan,
L. Petruželka,
Xuan Dung Pham,
P. Picon,
B. Pikó,
A. Poltoratsky,
Patrice Popelkova,
G. Purkalne,
S. Qin,
R. Ramlau,
Bernardo Rappaport,
Felipe Rey,
E. Richardet,
J. Roubec,
P. Ruff,
A. Rusyn,
H. Saka,
J. Salas,
Mario Sandoval,
L. Santos,
T. Sawa,
K. Seetalarom,
M. Seker,
N. Seki,
Freddy Seolwane,
L. Shepherd,
Sergii Shevnya,
A. Shimada,
Y. Shparyk,
I. Sinielnikov,
D. Sirbu,
O. Smaletz,
João Paulo Holanda Soares,
A. Sookprasert,
G. Speranza,
V. Sriuranpong,
Zinaida Stara,
W. Su,
S. Sugawara,
W. Szpak,
Kazuhisa Takahashi,
N. Takigawa,
Hiroshi Tanaka,
Jerry Tan Chun Bing,
Q. Tang,
P. Taranov,
H. Tejada,
L. Tho,
Yoshitaro Torii,
Dmytro Trukhyn,
M. Turdean,
H. Turna,
G. Ursol,
J. Vaňásek,
M. Varela,
M. Vallejo,
Luis Vera,
A. Victorino,
T. Vlásek,
I. Vynnychenko,
Buhai Wang,
Jie Wang,
Kai Wang,
Yilong Wu,
Kazuhiko Yamada,
Chih‐Hsin Yang,
T. Yokoyama,
T. Yokoyama,
H. Yoshioka,
F. Yumuk,
A. Zambrano,
J. Zarbá,
Oleg Zarubenkov,
Marius Žemaitis,
Li Zhang,
Xin Zhang,
Jun Zhao,
Caicun Zhou,
Jianying Zhou,
Qing Zhou,
A. Zippelius
|
11 |
2019 |
11
🐜
|
|
🐜
|
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
26 auth.
M. Hellmann,
L. Paz-Ares,
R. Bernabé Caro,
B. Żurawski,
Sang-We Kim,
E. Carcereny Costa,
Keunchil Park,
A. Alexandru,
L. Lupinacci,
Emmanuel de la Mora Jimenez,
H. Sakai,
I. Albert,
A. Vergnenègre,
S. Peters,
K. Syrigos,
...
F. Barlesi,
M. Reck,
H. Borghaei,
J. Brahmer,
K. O'Byrne,
W. Geese,
P. Bhagavatheeswaran,
S. Rabindran,
Ravi S. Kasinathan,
F. Nathan,
S. Ramalingam
|
10 |
2019 |
10
🐜
|
|
🐜
|
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
27 auth.
L. Paz-Ares,
T. Ciuleanu,
M. Cobo,
M. Schenker,
B. Żurawski,
J. Menezes,
E. Richardet,
J. Bennouna,
E. Felip,
Ó. Juan-Vidal,
A. Alexandru,
H. Sakai,
A. Lingua,
P. Salman,
P. Souquet,
...
P. De Marchi,
C. Martin,
M. Pérol,
A. Scherpereel,
Shun Lu,
T. John,
D. Carbone,
S. Meadows-Shropshire,
S. Agrawal,
A. Oukessou,
Jinchun Yan,
M. Reck
|
9 |
2021 |
9
🐜
|
|
🐜
|
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small Cell Lung Cancer: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial.
39 auth.
L. Paz-Ares,
S. Ramalingam,
T. Ciuleanu,
Jong-Seok Lee,
L. Urban,
R. B. Caro,
Keunchil Park,
H. Sakai,
Y. Ohe,
M. Nishio,
C. Audigier-Valette,
J. Burgers,
A. Płużański,
R. Sangha,
C. Gallardo,
...
M. Takeda,
H. Linardou,
L. Lupinacci,
K. Lee,
C. Caserta,
M. Provencio,
E. Carcereny,
G. Otterson,
M. Schenker,
B. Żurawski,
A. Alexandru,
A. Vergnenègre,
J. Raimbourg,
K. Feeney,
Sang-We Kim,
H. Borghaei,
K. O'Byrne,
M. Hellmann,
A. Memaj,
F. Nathan,
J. Bushong,
P. Tran,
J. Brahmer,
M. Reck
|
7 |
2021 |
7
🐜
|
|
🐜
|
Perioperative Nivolumab in Resectable Lung Cancer.
29 auth.
T. Cascone,
M. Awad,
Jonathan D Spicer,
Jie He,
Shun Lu,
B. Sepesi,
Fumihiro Tanaka,
Janis M. Taube,
R. Cornelissen,
L. Havel,
N. Karaseva,
J. Kuzdzal,
L.B. Petruzelka,
Lin Wu,
J-L. Pujol,
...
Hiroyuki Ito,
T. Ciuleanu,
Ludmila de Oliveira Muniz Koch,
Annelies Janssens,
A. Alexandru,
S. Bohnet,
Fedor V Moiseyenko,
Yang Gao,
Yasutaka Watanabe,
C. Coronado Erdmann,
P. Sathyanarayana,
Stephanie L. Meadows-Shropshire,
Steven I Blum,
Mariano Provencio Pulla
|
6 |
2024 |
6
🐜
|
|
🐜
|
First-line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic Non–Small Cell Lung Cancer in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations
32 auth.
L. Paz-Ares,
T. Ciuleanu,
M. Cobo,
J. Bennouna,
M. Schenker,
Ying Cheng,
Ó. Juan-Vidal,
H. Mizutani,
A. Lingua,
Felipe Reyes-Cosmelli,
N. Reinmuth,
J. Menezes,
J. Jassem,
S. Protsenko,
E. Richardet,
...
E. Felip,
K. Feeney,
B. Żurawski,
A. Alexandru,
Emmanuel de la Mora Jimenez,
S. Dakhil,
Shun Lu,
M. Reck,
T. John,
N. Hu,
Xiaoqing Zhang,
J. Sylvester,
Laura J. Eccles,
D. Grootendorst,
D. Balli,
J. Neely,
D. Carbone
|
5 |
2022 |
5
🐜
|
|
🐜
|
Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis
20 auth.
Solange Peters,
S. Ramalingam,
L. Paz-Ares,
R. B. Caro,
B. Żurawski,
Sang We Kim,
A. Alexandru,
L. Lupinacci,
E. Jiménez,
H. Sakai,
...
I. Albert,
A. Vergnenègre,
M. Reck,
H. Borghaei,
J. Brahmer,
K. O'Byrne,
W. Geese,
P. Bhagavatheeswaran,
F. Nathan,
M. Hellmann
|
5 |
2019 |
5
🐜
|
|
🐜
|
Systemic and intracranial outcomes with first-line nivolumab plus ipilimumab in patients with metastatic non-small cell lung cancer and baseline brain metastases from CheckMate 227 Part 1.
27 auth.
M. Reck,
T. Ciuleanu,
Jong-Seok Lee,
M. Schenker,
B. Żurawski,
Sang-We Kim,
M. Mahave,
A. Alexandru,
Solange Peters,
A. Płużański,
R. B. Caro,
H. Linardou,
J. Burgers,
M. Nishio,
A. Martínez-Martí,
...
K. Azuma,
R. Axelrod,
L. Paz-Ares,
S. Ramalingam,
H. Borghaei,
K. O'Byrne,
Li Li,
J. Bushong,
Ravi G. Gupta,
D. Grootendorst,
Laura J. Eccles,
J. Brahmer
|
5 |
2023 |
5
🐜
|
|
🐜
|
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial
26 auth.
David P. Carbone,
T. Ciuleanu,
M. Schenker,
M. Cobo,
S. Bordenave,
Ó. Juan-Vidal,
J. Menezes,
Niels Reinmuth,
E. Richardet,
Ying Cheng,
H. Mizutani,
E. Felip,
B. Żurawski,
A. Alexandru,
L. Paz-Ares,
...
Shun Lu,
Thomas John,
Xiaoqing Zhang,
Javed Mahmood,
Nan Hu,
Tuli De,
Irene Santi,
J. Penrod,
Yong Yuan,
Adam Lee,
Martin Reck
|
4 |
2024 |
4
🐜
|
|
🐜
|
Abstract CT221: Nivolumab (NIVO) + ipilimumab (IPI) as first-line (1L) treatment for patients with advanced non-small cell lung cancer (NSCLC) with brain metastases: Results from CheckMate 227
18 auth.
H. Borghaei,
A. Płużański,
R. B. Caro,
M. Provencio,
S. Burgers,
E. Carcereny,
Keunchil Park,
A. Alexandru,
L. Lupinacci,
R. Sangha,
...
J. Raimbourg,
A. Vergnenègre,
K. Syrigos,
F. Barlesi,
N. Frickhofen,
A. Li,
Ravi S. Kasinathan,
L. Paz-Ares
|
4 |
2020 |
4
🐜
|
|
🐜
|
Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with resectable NSCLC: 4-year update from CheckMate 816.
20 auth.
Jonathan D Spicer,
Nicolas Girard,
Mariano Provencio,
Changli Wang,
Tetsuya Mitsudomi,
M. Awad,
E. Vokes,
Janis M. Taube,
L. Lupinacci,
G. Saylors,
...
Fumihiro Tanaka,
Moishe Liberman,
S. Lee,
A. Alexandru,
M. D'Arcangelo,
P. Tran,
Javed Mahmood,
Vishwanath Gharpure,
Apurva Bhingare,
P. Forde
|
4 |
2024 |
4
🐜
|
|
🐜
|
Diagnosis and treatment protocols of cutaneous melanoma: latest approach 2010.
8 auth.
I. Petrescu,
C. Condrea,
A. Alexandru,
D. Dumitrescu,
G. Simion,
E. Severin,
...
C. Albu,
D. Albu
|
3 |
2010 |
3
🐜
|
